speb/financial-data huggingface dataset:
CRMT balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 644033000.00
CRMT cash_flow (quarterly, 2025-10-31) — Sale Of PPE: 97000.00
CRMT income_statement (quarterly, 2025-10-31) — Selling General And Administration: 57222000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Share Issued: 15645710.00
CRMT income_statement (quarterly, 2025-10-31) — Special Income Charges: -4576000.00
CRMT cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 1189000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 555426000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 531341000.00
CRMT income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: -834346.18
CRMT income_statement (quarterly, 2025-10-31) — Tax Provision: -5011000.00
CRMT income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.18
CRMT balance_sheet (quarterly, 2025-10-31) — Taxes Receivable: 7704000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Assets: 1717920000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 1190460000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Debt: 962766000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 555526000.00
CRMT income_statement (quarterly, 2025-10-31) — Total Expenses: 357414000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 1162394000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 174947000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 727434000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 1704000.00
CRMT income_statement (quarterly, 2025-10-31) — Total Unusual Items: -4576000.00
CRMT income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: -4576000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 7351190.00
CRMT balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 298496000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Working Capital: 1108013000.00
CRMT income_statement (quarterly, 2026-01-31) — +Operating Expense: 158754000.00
CRMT income_statement (quarterly, 2026-01-31) — +Total Revenue: 286792000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 19013000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 1114067000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Accrued Interest Receivable: 7477000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -63336000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 210360000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Allowance For Doubtful Accounts Receivable: -347565000.00
CRMT cash_flow (quarterly, 2026-01-31) — Asset Impairment Charge: 3660000.00
CRMT income_statement (quarterly, 2026-01-31) — Basic Average Shares: 8297438.00
CRMT income_statement (quarterly, 2026-01-31) — Basic EPS: -9.25
CRMT cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 250971000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Buildings And Improvements: 23718000.00
CRMT cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -278000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 60034000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Capital Stock: 557000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 117910000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 117910000.00
CRMT cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: -10000.00
CRMT cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -7834000.00
CRMT cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -241000.00
CRMT cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -5919000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Inventory: 33260000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: -5856000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -24897000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 1678000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Receivables: -86911000.00
CRMT cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -82726000.00
CRMT cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -86955000.00
CRMT cash_flow (quarterly, 2026-01-31) — Changes In Cash: -13994000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Common Stock: 157000.00
CRMT cash_flow (quarterly, 2026-01-31) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 479317000.00
CRMT cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 58000.00
CRMT cash_flow (quarterly, 2026-01-31) — Common Stock Payments: -23000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Construction In Progress: 449000.00
CRMT income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 142864000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 11707000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Assets: 1464483000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Debt: 263836000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 263836000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 100193000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 100193000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 396065000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Current Notes Payable: 263836000.00
CRMT cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: 29260000.00
CRMT cash_flow (quarterly, 2026-01-31) — Deferred Tax: 29260000.00
CRMT cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 2040000.00
CRMT income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 2040000.00
CRMT cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 2040000.00
CRMT income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 2040000.00
CRMT income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 8297438.00
CRMT income_statement (quarterly, 2026-01-31) — Diluted EPS: -9.25
CRMT income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -76713000.00
CRMT income_statement (quarterly, 2026-01-31) — EBIT: -14946000.00
CRMT income_statement (quarterly, 2026-01-31) — EBITDA: -12906000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Employee Benefits: 10922000.00
CRMT cash_flow (quarterly, 2026-01-31) — End Cash Position: 236977000.00
CRMT cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -7834000.00
CRMT cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -6197000.00
CRMT cash_flow (quarterly, 2026-01-31) — Gain Loss On Sale Of PPE: 0.00
CRMT income_statement (quarterly, 2026-01-31) — Gain On Sale Of Ppe: -120000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Goodwill: 22774000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 22774000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Gross Accounts Receivable: 1461632000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Gross PPE: 167265000.00
CRMT income_statement (quarterly, 2026-01-31) — Gross Profit: 143928000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 0.00
CRMT income_statement (quarterly, 2026-01-31) — Interest Expense: 21775000.00
CRMT income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 21775000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Interest Payable: 1198000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Inventory: 101178000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Invested Capital: 1371477000.00
CRMT cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -241000.00
CRMT cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 58000.00
CRMT cash_flow (quarterly, 2026-01-31) — Issuance Of Debt: 161264000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Land And Improvements: 11998000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Leases: 50260000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Line Of Credit: 0.00
CRMT balance_sheet (quarterly, 2026-01-31) — Loans Receivable: 605000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 60034000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 628324000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 688358000.00
CRMT cash_flow (quarterly, 2026-01-31) — Long Term Debt Issuance: -153329000.00
CRMT cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: 354622000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Machinery Furniture Equipment: 26060000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Minority Interest: 100000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 35000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Net Debt: 774250000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income: -76703000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -76713000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -76703000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -76703000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -76703000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -76703000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -76703000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Interest Income: -21775000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: -5805000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: 201293000.00
CRMT income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -21775000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -2054000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Net PPE: 103929000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -241000.00
CRMT cash_flow (quarterly, 2026-01-31) — Net Short Term Debt Issuance: -207098000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 456943000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 51631000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 5116000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 46515000.00
CRMT income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -12786000.00
CRMT income_statement (quarterly, 2026-01-31) — Normalized Income: -76631000.00
CRMT cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -5919000.00
CRMT cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 0.00
CRMT income_statement (quarterly, 2026-01-31) — Operating Income: -14826000.00
CRMT income_statement (quarterly, 2026-01-31) — Operating Revenue: 286792000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 8302450.00
CRMT income_statement (quarterly, 2026-01-31) — Other Income Expense: -120000.00
CRMT cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 12373000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 35607000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Other Properties: 54780000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Payables: 20329000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 32036000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 400000.00
CRMT income_statement (quarterly, 2026-01-31) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Preferred Stock Equity: 400000.00
CRMT income_statement (quarterly, 2026-01-31) — Pretax Income: -36721000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Properties: 0.00
CRMT income_statement (quarterly, 2026-01-31) — Provision For Doubtful Accounts: 105207000.00
CRMT cash_flow (quarterly, 2026-01-31) — Provisionand Write Offof Assets: 105208000.00
CRMT cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -278000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Receivables: 1126328000.00
CRMT income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 142864000.00
CRMT income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 2040000.00
CRMT cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -168358000.00
CRMT cash_flow (quarterly, 2026-01-31) — Repurchase Of Capital Stock: -23000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Restricted Cash: 119067000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 567320000.00
CRMT cash_flow (quarterly, 2026-01-31) — Sale Of PPE: 37000.00
CRMT income_statement (quarterly, 2026-01-31) — Selling General And Administration: 51507000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Share Issued: 15654558.00
CRMT income_statement (quarterly, 2026-01-31) — Special Income Charges: -120000.00
CRMT cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 969000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 479717000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 456543000.00
CRMT income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -48000.00
CRMT income_statement (quarterly, 2026-01-31) — Tax Provision: 39982000.00
CRMT income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.40
CRMT balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 4179000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Assets: 1626793000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 1108041000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Debt: 952194000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 479817000.00
CRMT income_statement (quarterly, 2026-01-31) — Total Expenses: 301618000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1146976000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 162310000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 750911000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 1316000.00
CRMT income_statement (quarterly, 2026-01-31) — Total Unusual Items: -120000.00
CRMT income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -120000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 7352108.00
CRMT balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 298520000.00
CRMT balance_sheet (quarterly, 2026-01-31) — Working Capital: 1068418000.00
CRMT income_statement (annual, 2026-04-30) — +Operating Expense: 635521000.00
CRMT income_statement (quarterly, 2026-04-30) — +Operating Expense: 141406000.00
CRMT income_statement (annual, 2026-04-30) — +Total Revenue: 1281502000.00
CRMT income_statement (quarterly, 2026-04-30) — +Total Revenue: 302826000.00
CRMT balance_sheet (annual, 2026-04-30) — Accounts Payable: 32063000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 32063000.00
CRMT balance_sheet (annual, 2026-04-30) — Accounts Receivable: 1078589000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 1078589000.00
CRMT balance_sheet (annual, 2026-04-30) — Accrued Interest Receivable: 8029000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Accrued Interest Receivable: 8029000.00
CRMT balance_sheet (annual, 2026-04-30) — Accumulated Depreciation: -64215000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -64215000.00
CRMT balance_sheet (annual, 2026-04-30) — Additional Paid In Capital: 210806000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 210806000.00
CRMT balance_sheet (annual, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -329901000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Allowance For Doubtful Accounts Receivable: -329901000.00
CRMT cash_flow (annual, 2026-04-30) — Asset Impairment Charge: 11052000.00
CRMT cash_flow (quarterly, 2026-04-30) — Asset Impairment Charge: 6390000.00
CRMT income_statement (annual, 2026-04-30) — Basic Average Shares: 8289319.00
CRMT income_statement (annual, 2026-04-30) — Basic EPS: -16.79
CRMT cash_flow (annual, 2026-04-30) — Beginning Cash Position: 124537000.00
CRMT cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 236977000.00
CRMT balance_sheet (annual, 2026-04-30) — Buildings And Improvements: 21718000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Buildings And Improvements: 21718000.00
CRMT cash_flow (annual, 2026-04-30) — Capital Expenditure: -1810000.00
CRMT cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -289000.00
CRMT balance_sheet (annual, 2026-04-30) — Capital Lease Obligations: 49833000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 49833000.00
CRMT balance_sheet (annual, 2026-04-30) — Capital Stock: 557000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Capital Stock: 557000.00
CRMT balance_sheet (annual, 2026-04-30) — Cash And Cash Equivalents: 46962000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 46962000.00
CRMT balance_sheet (annual, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 46962000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 46962000.00
CRMT cash_flow (annual, 2026-04-30) — Cash Dividends Paid: -40000.00
CRMT cash_flow (quarterly, 2026-04-30) — Cash Dividends Paid: -10000.00
CRMT cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Financing Activities: -56329000.00
CRMT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -172914000.00
CRMT cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Investing Activities: -1521000.00
CRMT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -154000.00
CRMT cash_flow (annual, 2026-04-30) — Cash Flow From Continuing Operating Activities: 64959000.00
CRMT cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 67737000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Inventory: 180287000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Inventory: 78490000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Other Working Capital: -21806000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -3124000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Payables And Accrued Expense: -2828000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 9321000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Prepaid Assets: 5953000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: 3840000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Receivables: -475318000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Receivables: -96165000.00
CRMT cash_flow (annual, 2026-04-30) — Change In Working Capital: -313712000.00
CRMT cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -7638000.00
CRMT cash_flow (annual, 2026-04-30) — Changes In Account Receivables: -474721000.00
CRMT cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: -95614000.00
CRMT cash_flow (annual, 2026-04-30) — Changes In Cash: 7109000.00
CRMT cash_flow (quarterly, 2026-04-30) — Changes In Cash: -105331000.00
CRMT balance_sheet (annual, 2026-04-30) — Common Stock: 157000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Common Stock: 157000.00
CRMT cash_flow (annual, 2026-04-30) — Common Stock Dividend Paid: -40000.00
CRMT cash_flow (quarterly, 2026-04-30) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (annual, 2026-04-30) — Common Stock Equity: 445556000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 445556000.00
CRMT cash_flow (annual, 2026-04-30) — Common Stock Issuance: 218000.00
CRMT cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 40000.00
CRMT cash_flow (annual, 2026-04-30) — Common Stock Payments: -297000.00
CRMT cash_flow (quarterly, 2026-04-30) — Common Stock Payments: 2000.00
CRMT balance_sheet (annual, 2026-04-30) — Construction In Progress: 297000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Construction In Progress: 297000.00
CRMT income_statement (annual, 2026-04-30) — Cost Of Revenue: 663981000.00
CRMT income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 167021000.00
CRMT balance_sheet (annual, 2026-04-30) — Current Accrued Expenses: 11526000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 11526000.00
CRMT balance_sheet (annual, 2026-04-30) — Current Assets: 1276440000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Current Assets: 1276440000.00
CRMT balance_sheet (annual, 2026-04-30) — Current Deferred Liabilities: 101745000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 101745000.00
CRMT balance_sheet (annual, 2026-04-30) — Current Deferred Revenue: 101745000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 101745000.00
CRMT balance_sheet (annual, 2026-04-30) — Current Liabilities: 146767000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 146767000.00
CRMT cash_flow (annual, 2026-04-30) — Deferred Income Tax: 27061000.00
CRMT cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: -2807000.00
CRMT cash_flow (annual, 2026-04-30) — Deferred Tax: 27061000.00
CRMT cash_flow (quarterly, 2026-04-30) — Deferred Tax: -2807000.00
CRMT cash_flow (annual, 2026-04-30) — Depreciation Amortization Depletion: 8207000.00
CRMT cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 1926000.00
CRMT income_statement (annual, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 8207000.00
CRMT income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 1926000.00
CRMT cash_flow (annual, 2026-04-30) — Depreciation And Amortization: 8207000.00
CRMT cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 1926000.00
CRMT income_statement (annual, 2026-04-30) — Depreciation And Amortization In Income Statement: 8207000.00
CRMT income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 1926000.00
CRMT income_statement (annual, 2026-04-30) — Diluted Average Shares: 8289319.00
CRMT income_statement (annual, 2026-04-30) — Diluted EPS: -16.79
CRMT income_statement (annual, 2026-04-30) — Diluted NI Availto Com Stockholders: -139151000.00
CRMT income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -34210000.00
CRMT income_statement (annual, 2026-04-30) — EBIT: -33487000.00
CRMT income_statement (quarterly, 2026-04-30) — EBIT: -16383000.00
CRMT income_statement (annual, 2026-04-30) — EBITDA: -25280000.00
CRMT income_statement (quarterly, 2026-04-30) — EBITDA: -14457000.00
CRMT balance_sheet (annual, 2026-04-30) — Employee Benefits: 9020000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Employee Benefits: 9020000.00
CRMT cash_flow (annual, 2026-04-30) — End Cash Position: 131646000.00
CRMT cash_flow (quarterly, 2026-04-30) — End Cash Position: 131646000.00
CRMT cash_flow (annual, 2026-04-30) — Financing Cash Flow: -56329000.00
CRMT cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -172914000.00
CRMT cash_flow (annual, 2026-04-30) — Free Cash Flow: 63149000.00
CRMT cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 67448000.00
CRMT cash_flow (annual, 2026-04-30) — Gain Loss On Sale Of PPE: 0.00
CRMT cash_flow (quarterly, 2026-04-30) — Gain Loss On Sale Of PPE: 0.00
CRMT income_statement (annual, 2026-04-30) — Gain On Sale Of Ppe: 5000.00
CRMT income_statement (quarterly, 2026-04-30) — Gain On Sale Of Ppe: 234000.00
CRMT balance_sheet (annual, 2026-04-30) — Goodwill: 22767000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Goodwill: 22767000.00
CRMT balance_sheet (annual, 2026-04-30) — Goodwill And Other Intangible Assets: 22767000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 22767000.00
CRMT balance_sheet (annual, 2026-04-30) — Gross Accounts Receivable: 1408490000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Gross Accounts Receivable: 1408490000.00
CRMT balance_sheet (annual, 2026-04-30) — Gross PPE: 150499000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Gross PPE: 150499000.00
CRMT income_statement (annual, 2026-04-30) — Gross Profit: 617521000.00
CRMT income_statement (quarterly, 2026-04-30) — Gross Profit: 135805000.00
CRMT cash_flow (annual, 2026-04-30) — Income Tax Paid Supplemental Data: 9174000.00
CRMT balance_sheet (annual, 2026-04-30) — Income Tax Payable: 0.00
CRMT balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 0.00
CRMT income_statement (annual, 2026-04-30) — Interest Expense: 74494000.00
CRMT income_statement (quarterly, 2026-04-30) — Interest Expense: 19992000.00
CRMT income_statement (annual, 2026-04-30) — Interest Expense Non Operating: 74494000.00
CRMT income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 19992000.00
CRMT cash_flow (annual, 2026-04-30) — Interest Paid Supplemental Data: 78570000.00
CRMT balance_sheet (annual, 2026-04-30) — Interest Payable: 805000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Interest Payable: 805000.00
CRMT balance_sheet (annual, 2026-04-30) — Inventory: 54074000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Inventory: 54074000.00
CRMT balance_sheet (annual, 2026-04-30) — Invested Capital: 1167922000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Invested Capital: 1167922000.00
CRMT cash_flow (annual, 2026-04-30) — Investing Cash Flow: -1521000.00
CRMT cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -154000.00
CRMT cash_flow (annual, 2026-04-30) — Issuance Of Capital Stock: 218000.00
CRMT cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 40000.00
CRMT cash_flow (annual, 2026-04-30) — Issuance Of Debt: 1151817000.00
CRMT cash_flow (quarterly, 2026-04-30) — Issuance Of Debt: 0.00
CRMT balance_sheet (annual, 2026-04-30) — Land And Improvements: 11883000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Land And Improvements: 11883000.00
CRMT balance_sheet (annual, 2026-04-30) — Leases: 47261000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Leases: 47261000.00
CRMT balance_sheet (annual, 2026-04-30) — Line Of Credit: 0.00
CRMT balance_sheet (quarterly, 2026-04-30) — Line Of Credit: 0.00
CRMT balance_sheet (annual, 2026-04-30) — Loans Receivable: 578000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Loans Receivable: 578000.00
CRMT balance_sheet (annual, 2026-04-30) — Long Term Capital Lease Obligation: 49833000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 49833000.00
CRMT balance_sheet (annual, 2026-04-30) — Long Term Debt: 722366000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 722366000.00
CRMT balance_sheet (annual, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 772199000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 772199000.00
CRMT cash_flow (annual, 2026-04-30) — Long Term Debt Issuance: 1151817000.00
CRMT cash_flow (quarterly, 2026-04-30) — Long Term Debt Issuance: 314593000.00
CRMT cash_flow (annual, 2026-04-30) — Long Term Debt Payments: -1184736000.00
CRMT cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -692449000.00
CRMT balance_sheet (annual, 2026-04-30) — Machinery Furniture Equipment: 25911000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Machinery Furniture Equipment: 25911000.00
CRMT balance_sheet (annual, 2026-04-30) — Minority Interest: 100000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Minority Interest: 100000.00
CRMT cash_flow (annual, 2026-04-30) — Net Common Stock Issuance: -79000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 42000.00
CRMT balance_sheet (annual, 2026-04-30) — Net Debt: 675404000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Net Debt: 675404000.00
CRMT income_statement (annual, 2026-04-30) — Net Income: -139111000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income: -34200000.00
CRMT income_statement (annual, 2026-04-30) — Net Income Common Stockholders: -139151000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -34210000.00
CRMT income_statement (annual, 2026-04-30) — Net Income Continuous Operations: -139111000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -34200000.00
CRMT income_statement (annual, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -139111000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -34200000.00
CRMT income_statement (annual, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -139111000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -34200000.00
CRMT cash_flow (annual, 2026-04-30) — Net Income From Continuing Operations: -139111000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -34200000.00
CRMT income_statement (annual, 2026-04-30) — Net Income Including Noncontrolling Interests: -139111000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -34200000.00
CRMT income_statement (annual, 2026-04-30) — Net Interest Income: -74494000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Interest Income: -19992000.00
CRMT cash_flow (annual, 2026-04-30) — Net Investment Purchase And Sale: 0.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 0.00
CRMT cash_flow (annual, 2026-04-30) — Net Issuance Payments Of Debt: -34208000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -170758000.00
CRMT cash_flow (annual, 2026-04-30) — Net Long Term Debt Issuance: -32919000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -377856000.00
CRMT income_statement (annual, 2026-04-30) — Net Non Operating Interest Income Expense: -74494000.00
CRMT income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -19992000.00
CRMT cash_flow (annual, 2026-04-30) — Net Other Financing Charges: -22002000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -2188000.00
CRMT balance_sheet (annual, 2026-04-30) — Net PPE: 86284000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Net PPE: 86284000.00
CRMT cash_flow (annual, 2026-04-30) — Net PPE Purchase And Sale: -1521000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -154000.00
CRMT cash_flow (annual, 2026-04-30) — Net Short Term Debt Issuance: -1289000.00
CRMT cash_flow (quarterly, 2026-04-30) — Net Short Term Debt Issuance: 207098000.00
CRMT balance_sheet (annual, 2026-04-30) — Net Tangible Assets: 423189000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 423189000.00
CRMT balance_sheet (annual, 2026-04-30) — Non Current Deferred Liabilities: 42798000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 42798000.00
CRMT balance_sheet (annual, 2026-04-30) — Non Current Deferred Taxes Liabilities: 42798000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 42798000.00
CRMT income_statement (annual, 2026-04-30) — Normalized EBITDA: -9793000.00
CRMT income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -3675000.00
CRMT income_statement (annual, 2026-04-30) — Normalized Income: -129818800.00
CRMT income_statement (quarterly, 2026-04-30) — Normalized Income: -24062696.91
CRMT cash_flow (annual, 2026-04-30) — Operating Cash Flow: 64959000.00
CRMT cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 67737000.00
CRMT cash_flow (annual, 2026-04-30) — Operating Gains Losses: 2726000.00
CRMT cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: 0.00
CRMT income_statement (annual, 2026-04-30) — Operating Income: -18000000.00
CRMT income_statement (quarterly, 2026-04-30) — Operating Income: -5601000.00
CRMT income_statement (annual, 2026-04-30) — Operating Revenue: 1281502000.00
CRMT income_statement (quarterly, 2026-04-30) — Operating Revenue: 302826000.00
CRMT balance_sheet (annual, 2026-04-30) — Ordinary Shares Number: 8305520.00
CRMT balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 8305520.00
CRMT income_statement (annual, 2026-04-30) — Other Income Expense: -15487000.00
CRMT income_statement (quarterly, 2026-04-30) — Other Income Expense: -10782000.00
CRMT cash_flow (annual, 2026-04-30) — Other Non Cash Items: 45784000.00
CRMT cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 11746000.00
CRMT balance_sheet (annual, 2026-04-30) — Other Non Current Assets: 31349000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 31349000.00
CRMT balance_sheet (annual, 2026-04-30) — Other Properties: 43429000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Other Properties: 43429000.00
CRMT income_statement (annual, 2026-04-30) — Other Special Charges: 4476000.00
CRMT income_statement (quarterly, 2026-04-30) — Other Special Charges: 0.00
CRMT balance_sheet (annual, 2026-04-30) — Payables: 33496000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Payables: 33496000.00
CRMT balance_sheet (annual, 2026-04-30) — Payables And Accrued Expenses: 45022000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 45022000.00
CRMT balance_sheet (annual, 2026-04-30) — Preferred Stock: 400000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 400000.00
CRMT income_statement (annual, 2026-04-30) — Preferred Stock Dividends: 40000.00
CRMT income_statement (quarterly, 2026-04-30) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (annual, 2026-04-30) — Preferred Stock Equity: 400000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Preferred Stock Equity: 400000.00
CRMT income_statement (annual, 2026-04-30) — Pretax Income: -107981000.00
CRMT income_statement (quarterly, 2026-04-30) — Pretax Income: -36375000.00
CRMT cash_flow (annual, 2026-04-30) — Proceeds From Stock Option Exercised: 0.00
CRMT balance_sheet (annual, 2026-04-30) — Properties: 0.00
CRMT balance_sheet (quarterly, 2026-04-30) — Properties: 0.00
CRMT income_statement (annual, 2026-04-30) — Provision For Doubtful Accounts: 419230000.00
CRMT income_statement (quarterly, 2026-04-30) — Provision For Doubtful Accounts: 91913000.00
CRMT cash_flow (annual, 2026-04-30) — Provisionand Write Offof Assets: 419230000.00
CRMT cash_flow (quarterly, 2026-04-30) — Provisionand Write Offof Assets: 91913000.00
CRMT cash_flow (annual, 2026-04-30) — Purchase Of Investment: 0.00
CRMT cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: 0.00
CRMT cash_flow (annual, 2026-04-30) — Purchase Of PPE: -1810000.00
CRMT cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -289000.00
CRMT balance_sheet (annual, 2026-04-30) — Receivables: 1090720000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Receivables: 1090720000.00
CRMT income_statement (annual, 2026-04-30) — Reconciled Cost Of Revenue: 663981000.00
CRMT income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 167021000.00
CRMT income_statement (annual, 2026-04-30) — Reconciled Depreciation: 8207000.00
CRMT income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 1926000.00
CRMT cash_flow (annual, 2026-04-30) — Repayment Of Debt: -1184736000.00
CRMT cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -169469000.00
CRMT cash_flow (annual, 2026-04-30) — Repurchase Of Capital Stock: -297000.00
CRMT cash_flow (quarterly, 2026-04-30) — Repurchase Of Capital Stock: 2000.00
CRMT balance_sheet (annual, 2026-04-30) — Restricted Cash: 84684000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Restricted Cash: 84684000.00
CRMT balance_sheet (annual, 2026-04-30) — Retained Earnings: 533110000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 533110000.00
CRMT cash_flow (annual, 2026-04-30) — Sale Of PPE: 289000.00
CRMT cash_flow (quarterly, 2026-04-30) — Sale Of PPE: 135000.00
CRMT income_statement (annual, 2026-04-30) — Selling General And Administration: 208084000.00
CRMT income_statement (quarterly, 2026-04-30) — Selling General And Administration: 47567000.00
CRMT balance_sheet (annual, 2026-04-30) — Share Issued: 15657592.00
CRMT balance_sheet (quarterly, 2026-04-30) — Share Issued: 15657592.00
CRMT income_statement (annual, 2026-04-30) — Special Income Charges: -15487000.00
CRMT income_statement (quarterly, 2026-04-30) — Special Income Charges: -10782000.00
CRMT cash_flow (annual, 2026-04-30) — Stock Based Compensation: 3722000.00
CRMT cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 407000.00
CRMT balance_sheet (annual, 2026-04-30) — Stockholders Equity: 445956000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 445956000.00
CRMT balance_sheet (annual, 2026-04-30) — Tangible Book Value: 422789000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 422789000.00
CRMT income_statement (annual, 2026-04-30) — Tax Effect Of Unusual Items: -6194800.00
CRMT income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: -644696.91
CRMT income_statement (annual, 2026-04-30) — Tax Provision: 31130000.00
CRMT income_statement (quarterly, 2026-04-30) — Tax Provision: -2175000.00
CRMT income_statement (annual, 2026-04-30) — Tax Rate For Calcs: 0.40
CRMT income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.06
CRMT balance_sheet (annual, 2026-04-30) — Taxes Receivable: 3524000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 3524000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Assets: 1416840000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Assets: 1416840000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Capitalization: 1168322000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 1168322000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Debt: 772199000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Debt: 772199000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Equity Gross Minority Interest: 446056000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 446056000.00
CRMT income_statement (annual, 2026-04-30) — Total Expenses: 1299502000.00
CRMT income_statement (quarterly, 2026-04-30) — Total Expenses: 308427000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Liabilities Net Minority Interest: 970784000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 970784000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Non Current Assets: 140400000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 140400000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 824017000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 824017000.00
CRMT balance_sheet (annual, 2026-04-30) — Total Tax Payable: 1433000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 1433000.00
CRMT income_statement (annual, 2026-04-30) — Total Unusual Items: -15487000.00
CRMT income_statement (quarterly, 2026-04-30) — Total Unusual Items: -10782000.00
CRMT income_statement (annual, 2026-04-30) — Total Unusual Items Excluding Goodwill: -15487000.00
CRMT income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: -10782000.00
CRMT balance_sheet (annual, 2026-04-30) — Treasury Shares Number: 7352072.00
CRMT balance_sheet (quarterly, 2026-04-30) — Treasury Shares Number: 7352072.00
CRMT balance_sheet (annual, 2026-04-30) — Treasury Stock: 298517000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 298517000.00
CRMT balance_sheet (annual, 2026-04-30) — Working Capital: 1129673000.00
CRMT balance_sheet (quarterly, 2026-04-30) — Working Capital: 1129673000.00
CRMT income_statement (annual, 2026-04-30) — Write Off: 11016000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 27023000.00
CRN.AX cash_flow (annual, 2021-12-31) — Common Stock Issuance: 97741000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Construction In Progress: 42055000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 25612000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Current Deferred Taxes Liabilities: 25612000.00
CRN.AX cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 97741000.00
CRN.AX cash_flow (annual, 2021-12-31) — Issuance Of Debt: 411524000.00
CRN.AX cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 411524000.00
CRN.AX income_statement (annual, 2021-12-31) — Minority Interests: 2000.00
CRN.AX cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 97741000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 14716000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 230492000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 14716000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Other Receivables: 13576000.00
CRN.AX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 24226000.00
CRN.AX income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 2300000.00
CRN.AX cash_flow (annual, 2021-12-31) — Sale Of PPE: 29045000.00
CRN.AX income_statement (annual, 2021-12-31) — Special Income Charges: -2300000.00
CRN.AX income_statement (annual, 2021-12-31) — Total Unusual Items: -2300000.00
CRN.AX income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -2300000.00
CRN.AX income_statement (annual, 2022-12-31) — +Operating Expense: 979712000.00
CRN.AX income_statement (annual, 2022-12-31) — +Total Revenue: 3527626000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Accounts Payable: 61780000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 409979000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 26214000.00
CRN.AX income_statement (annual, 2022-12-31) — Basic Average Shares: 16764500000.00
CRN.AX income_statement (annual, 2022-12-31) — Basic EPS: 0.05
CRN.AX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 437931000.00
CRN.AX cash_flow (annual, 2022-12-31) — Capital Expenditure: -199716000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 23293000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Capital Stock: 1093959000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 334629000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 334629000.00
CRN.AX cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -700244000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Cash Financial: 334629000.00
CRN.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -784251000.00
CRN.AX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -208343000.00
CRN.AX cash_flow (annual, 2022-12-31) — Cash Flowsfromusedin Operating Activities Direct: 926643000.00
CRN.AX cash_flow (annual, 2022-12-31) — Changes In Cash: -65951000.00
CRN.AX cash_flow (annual, 2022-12-31) — Classesof Cash Receiptsfrom Operating Activities: 926643000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Common Stock: 1093959000.00
CRN.AX cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -700244000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1103090000.00
CRN.AX cash_flow (annual, 2022-12-31) — Common Stock Issuance: -850202000.00
CRN.AX income_statement (annual, 2022-12-31) — Cost Of Revenue: 1515585000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Assets: 989028000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 7720000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 7720000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 119981000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Deferred Taxes Liabilities: 119981000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Liabilities: 600860000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Current Provisions: 10646000.00
CRN.AX income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 167046000.00
CRN.AX income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 167046000.00
CRN.AX income_statement (annual, 2022-12-31) — Depreciation Income Statement: 167046000.00
CRN.AX income_statement (annual, 2022-12-31) — Diluted Average Shares: 16764500000.00
CRN.AX income_statement (annual, 2022-12-31) — Diluted EPS: 0.05
CRN.AX income_statement (annual, 2022-12-31) — EBIT: 1070909000.00
CRN.AX income_statement (annual, 2022-12-31) — EBITDA: 1237955000.00
CRN.AX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -37351000.00
CRN.AX cash_flow (annual, 2022-12-31) — End Cash Position: 334629000.00
CRN.AX cash_flow (annual, 2022-12-31) — Financing Cash Flow: -784251000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Finished Goods: 45913000.00
CRN.AX cash_flow (annual, 2022-12-31) — Free Cash Flow: 726927000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Goodwill: 28008000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 31319000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Gross PPE: 1406933000.00
CRN.AX income_statement (annual, 2022-12-31) — Gross Profit: 2012041000.00
CRN.AX income_statement (annual, 2022-12-31) — Interest Expense: 67632000.00
CRN.AX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 67632000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Inventory: 254535000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Invested Capital: 1336043000.00
CRN.AX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -208343000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Investments And Advances: 89062000.00
CRN.AX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: -850202000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 15573000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Long Term Debt: 232953000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 248526000.00
CRN.AX cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -81310000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Long Term Provisions: 127844000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1389548000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -850202000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 771703000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Interest Income: -67632000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -8945000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -81310000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -81310000.00
CRN.AX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -67632000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2837000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Net PPE: 1406933000.00
CRN.AX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -199398000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1071771000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 95671000.00
CRN.AX balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 95671000.00
CRN.AX income_statement (annual, 2022-12-31) — Normalized EBITDA: 1237955000.00